Your browser doesn't support javascript.
loading
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
Kiiski, Johanna I; Tervasmäki, Anna; Pelttari, Liisa M; Khan, Sofia; Mantere, Tuomo; Pylkäs, Katri; Mannermaa, Arto; Tengström, Maria; Kvist, Anders; Borg, Åke; Kosma, Veli-Matti; Kallioniemi, Anne; Schleutker, Johanna; Bützow, Ralf; Blomqvist, Carl; Aittomäki, Kristiina; Winqvist, Robert; Nevanlinna, Heli.
  • Kiiski JI; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tervasmäki A; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Pelttari LM; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre, NordLab, Oulu, Finland.
  • Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Mantere T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Mannermaa A; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre, NordLab, Oulu, Finland.
  • Tengström M; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Kvist A; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre, NordLab, Oulu, Finland.
  • Borg Å; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Kosma VM; Imaging Center, Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Kallioniemi A; School of Medicine, Institute of Clinical Medicine, Oncology, Kuopio, Finland.
  • Schleutker J; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
  • Bützow R; Division of Oncology and Pathology Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
  • Blomqvist C; Division of Oncology and Pathology Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
  • Aittomäki K; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Winqvist R; Imaging Center, Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Nevanlinna H; BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, and Fimlab Laboratories, Tampere, Finland.
Breast Cancer Res Treat ; 166(1): 217-226, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28702895
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN Helicasas / Predisposición Genética a la Enfermedad / Alelos / Neoplasias de la Mama Triple Negativas / Mutación Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN Helicasas / Predisposición Genética a la Enfermedad / Alelos / Neoplasias de la Mama Triple Negativas / Mutación Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article